Loring Wolcott & Coolidge Fiduciary Advisors LLP Ptc Therapeutics, Inc. Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

$11.1 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Apr 14, 2021	SELL	$46.8 - $68.92 $6,645 - $9,786	-142 Closed	0 $0
Q4 2020 Jan 14, 2021	BUY	$47.96 - $67.64 $6,810 - $9,604	142 New	142 $9,000

Others Institutions Holding PTCT

# of Institutions

221

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

Vanguard Group Inc Valley Forge, PA

9.13M
Shares

$418 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

7.89M
Shares

$362 Million
0.05% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$356 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.39M
Shares

$339 Million
4.37% of portfolio
Armistice Capital, LLC New York, NY

7.23M
Shares

$332 Million
4.46% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.28B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Account